Terns Pharmaceuticals Inc.

TERN | NASDAQ

Price Alert Chart Builder DCF Calculator

$52.95

-$0.02 (-0.03%)

At close: May 15, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $4.77B

Enterprise Value $3.75B

Beta -0.38

Average Volume 5.79M

Shares Outstanding (Diluted) 93.17M

Shares Change YoY 2.11%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US8808811074

Price Performance

Price Change 1M 0.6%

Price Change 3M 34.2%

Price Change 6M 101.2%

Price Change YTD 32.0%

Price Change 1Y 1581.0%

Price Change 3Y 388.0%

Price Change 5Y 232.6%

1M CAGR (ann.) -0.4%

1Y CAGR (ann.) 1647.5%

5Y CAGR (ann.) 21.2%

All-Time CAGR 22.2%

Valuation

PE Ratio -51.41

Forward PE N/A

PEG Ratio -5.51

Forward PEG -2.17

PS Ratio N/A

Forward PS 827.10

PB Ratio 4.74

P/FCF Ratio -58.04

P/Adj. FCF Ratio -51.90

P/OCF Ratio -60.17

EV/Sales N/A

EV/EBIT -34.07

EV/EBITDA -34.07

EV/FCF -45.65

Earnings Yield -1.9%

FCF Yield -1.7%

Adj. FCF Yield -1.9%

Financial Health

Net Cash $1.02B

Total Debt $919K

Cash & Short-Term Investments $1.02B

Total Assets $1.03B

Current Ratio 62.41

Quick Ratio 62.41

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -89.43

Interest Coverage 0.00

Altman Z-Score 154.36

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -11.8%

Returns

Return on Assets -9.4%

Return on Equity -20.0%

Return on Invested Capital -10.9%

Return on Capital Employed -10.9%

Return on Tangible Assets -9.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 10.5%

EPS CAGR 5Y 18.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -10.1%

FCF CAGR 5Y -15.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 16

EPS Growth Next 3Y -15.5%

Revenue Growth Next 3Y N/A

Earnings Date May 13, 2026

EPS Estimate (next Q) -$0.30

EPS Growth Est (next Q) 15.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $53

Price Target Upside 0.1%

Cash Flow

Operating Cash Flow $-82.18M

Free Cash Flow $-82.18M

Adj. Free Cash Flow $-91.9M

FCF Per Share -$0.88

OCF Per Share -$0.88

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-110.12M

EBITDA $-110.12M

Net Income $-96.21M

EPS (Diluted) -$1.03

Revenue / Employee N/A

Profit / Employee $-1.63M

Employees 59